Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.26.3
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Total
Pre Funded Warrants [Member]
Common Stock
Common Stock
Pre Funded Warrants [Member]
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance at Dec. 31, 2024 $ 94,866,280   $ 69,362   $ 189,254,777 $ (37,248) $ (94,420,611)
Beginning balance, Shares at Dec. 31, 2024     69,362,439        
Stock-based compensation expense 2,042,196       2,042,196    
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs 2,460,501   $ 830   2,459,671    
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs, Shares     829,849        
Shares forfeited and contingent consideration reclassified to additional paid-in capital (see Note 9)     4,149,252        
Shares forfeited and contingent consideration reclassified to additional paid-in capital (see Note 9), value 4,149   $ 4,149        
Other comprehensive income loss 36,281         36,281  
Net Income (Loss) (13,678,735)           (13,678,735)
Ending balance at Mar. 31, 2025 85,730,672   $ 74,341   193,756,644 (967) (108,099,346)
Ending balance, Shares at Mar. 31, 2025     74,341,540        
Beginning balance at Dec. 31, 2024 94,866,280   $ 69,362   189,254,777 (37,248) (94,420,611)
Beginning balance, Shares at Dec. 31, 2024     69,362,439        
Net Income (Loss) (35,524,538)            
Ending balance at Sep. 30, 2025 72,898,298   $ 74,808   202,772,828 (4,189) (129,945,149)
Ending balance, Shares at Sep. 30, 2025     74,807,911        
Beginning balance at Mar. 31, 2025 85,730,672   $ 74,341   193,756,644 (967) (108,099,346)
Beginning balance, Shares at Mar. 31, 2025     74,341,540        
Stock-based compensation expense 4,208,742       4,208,742    
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs 150   $ 150        
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs, Shares     150,000        
Issuance of common stock, stock options exercised, Shares     25,095        
Issuance of common stock, stock options exercised, Value 31,621   $ 25   31,596    
Other comprehensive income loss (1,977)         (1,977)  
Net Income (Loss) (9,915,523)           (9,915,523)
Ending balance at Jun. 30, 2025 80,053,685   $ 74,516   197,996,982 (2,944) (118,014,869)
Ending balance, Shares at Jun. 30, 2025     74,516,635        
Stock-based compensation expense 4,525,206       4,525,206    
Issuance of common stock, stock options exercised, Shares     291,276        
Issuance of common stock, stock options exercised, Value 250,932   $ 292   250,640    
Other comprehensive income loss (1,245)         (1,245)  
Net Income (Loss) (11,930,280)           (11,930,280)
Ending balance at Sep. 30, 2025 72,898,298   $ 74,808   202,772,828 (4,189) (129,945,149)
Ending balance, Shares at Sep. 30, 2025     74,807,911        
Beginning balance at Dec. 31, 2025 $ 172,903,679   $ 131,691   315,429,986 21,802 (142,679,800)
Beginning balance, Shares at Dec. 31, 2025 131,691,237   131,691,237        
Stock-based compensation expense $ 5,559,766       5,559,766    
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs 2,897,611   $ 1,905   2,895,706    
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs, Shares     1,904,762        
Issuance of common stock, stock options exercised, Shares     96,341        
Issuance of common stock, stock options exercised, Value     $ 96   (96)    
Shares forfeited and contingent consideration reclassified to additional paid-in capital (see Note 9)     (1,659,704)        
Shares forfeited and contingent consideration reclassified to additional paid-in capital (see Note 9), value 2,688,147   $ (1,660)   2,689,807    
Other comprehensive income loss (48,095)         (48,095)  
Net Income (Loss) (16,380,840)           (16,380,840)
Ending balance at Mar. 31, 2026 167,620,268   $ 132,032   326,575,169 (26,293) (159,060,640)
Ending balance, Shares at Mar. 31, 2026     132,032,636        
Beginning balance at Dec. 31, 2025 $ 172,903,679   $ 131,691   315,429,986 21,802 (142,679,800)
Beginning balance, Shares at Dec. 31, 2025 131,691,237   131,691,237        
Net Income (Loss) $ (56,439,405)            
Ending balance at Sep. 30, 2026 $ 188,795,198   $ 140,270   387,883,494 (109,361) (199,119,205)
Ending balance, Shares at Sep. 30, 2026 140,269,633   140,269,633        
Beginning balance at Mar. 31, 2026 $ 167,620,268   $ 132,032   326,575,169 (26,293) (159,060,640)
Beginning balance, Shares at Mar. 31, 2026     132,032,636        
Stock-based compensation expense 5,346,010       5,346,010    
Other comprehensive income loss (46,461)         (46,461)  
Net Income (Loss) (19,591,231)           (19,591,231)
Ending balance at Jun. 30, 2026 153,328,586   $ 132,032   331,921,179 (72,754) (178,651,871)
Ending balance, Shares at Jun. 30, 2026     132,032,636        
Stock-based compensation expense 5,527,808       5,527,808    
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs 49,113,548 $ 18,030 $ 25,262 $ 18,030 49,088,286    
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs, Shares     25,261,500 18,030,000      
Issuance of common stock, stock options exercised, Shares     275,497        
Exercise of Series A-1 warrants, Share     730,000        
Exercise of Series A-1 warrants 1,000,100   $ 730   999,370    
Issuance of common stock, stock options exercised, Value 347,127   276   (346,851)    
Other comprehensive income loss (36,607)         (36,607)  
Net Income (Loss) (20,467,334)           (20,467,334)
Ending balance at Sep. 30, 2026 $ 188,795,198   $ 140,270   $ 387,883,494 $ (109,361) $ (199,119,205)
Ending balance, Shares at Sep. 30, 2026 140,269,633   140,269,633